γH2AX applications for the evaluation of telomerase-based cancer therapy

Cell Cycle

Volumn 9, Issue 17, 2010, Pages 3385-3386

  Nakamura, Asako J ^a   Redon, Christophe E ^a   Bonner, William M ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE H2AX; TELOMERASE;

CANCER GROWTH; CANCER THERAPY; DNA DAMAGE; DNA REPAIR; DNA REPLICATION; DNA STRAND BREAKAGE; DNA TRANSCRIPTION; EDITORIAL; HUMAN; TELOMERE;

EID: 77956414003     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.9.17.13003     Document Type: Editorial

References (11)

1. Sedelnikova OA, et al. Cell Cycle 2006; 5:2909-13.
2. Sedelnikova OA, et al. Mutat Res 2010; 704:152-9.
3. von Zglinicki T. Trends Biochem Sci 2002; 27:339-44.
4. Murnane JP. Cancer Res 2010; 70:4255-9.
5. Bonner WM, et al. Nat Rev Cancer 2008; 8:957-67.
6. Fruehauf JP, et al. Expert Rev Anticancer Ther 2008; 8:1751-7.
7. Harley CB. Nat Rev Cancer 2008; 8:167-79.
8. Nakamura AJ, et al. Aging 2009; 1:212-8.
9. Rogakou EP, et al. J Cell Biol 1999; 146:905-16.
10. Dickey JS, et al. Chromosoma 2009; 118:683-92.
11. Marian CO, et al. Clin Cancer Res 16:154-63.